| Literature DB >> 29862251 |
G Bori1, M A McNally2, N Athanasou2.
Abstract
The presence of a polymorphonuclear neutrophil infiltrate in periprosthetic tissues has been shown to correlate closely with the diagnosis of septic implant failure. The histological criterion considered by the Musculoskeletal Infection Society to be diagnostic of periprosthetic joint infection is "greater than five neutrophils per high-power field in five high-power fields observed from histologic analysis of periprosthetic tissue at ×400 magnification." Surgeons and pathologists should be aware of the qualifications introduced by different authors during the last years in the histological techniques, samples for histological study, cutoffs used for the diagnosis of infection, and types of patients studied. Recently, immunohistochemistry and histochemistry studies have appeared which suggest that the cutoff point of five polymorphonuclear neutrophils in five high-power fields is too high for the diagnosis of many periprosthetic joint infections. Therefore, morphomolecular techniques could help in the future to achieve a more reliable histological diagnosis of periprosthetic joint infection.Entities:
Mesh:
Year: 2018 PMID: 29862251 PMCID: PMC5971260 DOI: 10.1155/2018/1412701
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Summary of the main articles with the type of specimens used for the histological study and the histological criteria for interpretation of histology as diagnostic of infection.
| Reference | Specimen | Criteria |
|---|---|---|
| Mirra et al. (1976) [ | Synovial and capsular tissues | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (500x) |
|
| ||
| Fehring and McAlister (1994) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | Evidence of acute inflammation (no quantification) |
|
| ||
| Feldman et al. (1995) [ | Joint pseudocapsule and interface membrane | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Athanasou et al. (1995) [ | Joint pseudocapsule and interface membrane | ≥1 polymorphonuclear leukocyte per HPF on average in at least 10 HPF (400x) |
|
| ||
| Lonner et al. (1996) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 and ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Pace et al. (1997) [ | Joint pseudocapsule and interface membrane | ≥5 polymorphonuclear leukocytes per HPF on multiple (three) HPF (600x) |
|
| ||
| Abdul-Karim et al. (1998) [ | Interface membrane (aseptic suspicion). Interface membrane, synovial tissue, and unusually discolored tissue (septic suspicion) | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Spangehl et al. (1999) [ | Synovial surface | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
|
| ||
| Pandey et al. (1999) [ | Joint pseudocapsule and interface membrane | ≥1 polymorphonuclear leukocyte per HPF on average in at least 10 HPF (400x) |
|
| ||
| Pons et al. (1999) [ | Synovial surface | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Della Valle et al. (1999) [ | Joint pseudocapsule, granulation tissue, and any area that appeared suspicious for possible infection | - |
|
| ||
| Banit et al. (2002) [ | Joint pseudocapsule and any area that appeared suspicious for possible infection | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Musso et al. (2003) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Malhorta and Morgan (2004) [ | Joint pseudocapsule | ≥5 polymorphonuclear leukocytes per HPF in most areas (400x) |
|
| ||
| Ko et al. (2005) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
|
| ||
| Wong et al. (2005) [ | Synovial surface, joint pseudocapsule, and interface membrane | ≥5 and ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Francés Borrego et al. (2006) [ | Periprosthetic soft tissue | ≥10 polymorphonuclear leukocytes in any single HPF (400x) |
|
| ||
| Bori et al. (2006) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Morawietz et al. (2006) [ | Interface membrane | Evidence of acute inflammation (no quantification). Low or high grade. |
|
| ||
| Nuñez et al. (2007) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Nilsdotter-Augustinsson et al. (2007) [ | Synovial surface and interface membrane | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
|
| ||
| Della Valle et al. (2007) [ | Synovial surface | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Bori et al. (2007) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Kanner et al. (2008) [ | Periprosthetic soft tissue | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Müller et al. (2008) [ | Interface membrane | Evidence of acute inflammation (no quantification) |
|
| ||
| Schinsky et al. (2008) [ | Synovial surface | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Fink et al. (2008) [ | Periprosthetic tissue | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
|
| ||
| Schäfer et al. (2008) [ | Periprosthetic soft tissue and membrane | ≥5 polymorphonuclear leukocytes per HPF in ≥10 HPF (400x) |
|
| ||
| Savarino et al. (2009) [ | - | ≥1 polymorphonuclear leukocytes in any single HPF (600x) |
|
| ||
| Bori et al. (2009) [ | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Morawietz et al. (2009) [ | Interface membrane | ≥23 polymorphonuclear leukocytes in ≥10 HPF (400x) |
|
| ||
| Tohtz et al. (2010) [ | Interface membrane | ≥2 polymorphonuclear leukocytes per HPF in at least 10 HPF (400x) |
|
| ||
| Stroh et al. (2012) [ | Joint pseudocapsule, synovium, and soft tissue | Mean of greater than 5 polymorphonucleocytes (PMNs) per HPF was the criteria |
|
| ||
| Miyamae et al. (2013) [ | Periprosthetic tissue | ≥10 polymorphonuclear leukocytes in any single HPF (400x) |
|
| ||
| Ahmadi et al. (2013) [ | Periprosthetic tissue | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
|
| ||
| Muñoz-Mahamud et al. (2013) [ | Interface membrane | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Grosso et al. (2014) [ | Joint pseudocapsule and interface membrane | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
|
| ||
| Buttaro et al. (2015) [ | Joint pseudocapsule, interface membrane, and any other tissue involved according to the surgeon's judgment | ≥5 polymorphonuclear leukocytes per HPF in at least 10 HPF (400x) |
|
| ||
| Kashima et al. (2015) [ | Joint pseudocapsule and interface membrane | ≥2 polymorphonuclear leukocytes per HPF on average in at least 10 HPF (400x) |
≥1 polymorphonuclear leukocyte per HPF on average after examination of at least 10 HPF; ≥23 polymorphonuclear leukocytes in ≥10 HPF (400x). In each HPF, a maximum of 10 polymorphonuclear leukocytes were counted. The sum must be between zero and 100; ≥2 polymorphonuclear leukocytes per HPF on average after examination of at least 10 HPF.
Sensitivity, specificity, and positive and negative predictive values.
|
| Cutoff PMN |
|
| PPV (%) | NPV (%) | |
|---|---|---|---|---|---|---|
| Mirra et al. (1976) [ | 34 | 5 | 100 | 98 | - | - |
| Fehring and McAlister (1994) [ | 107 | Total | 18 | 89 | - | - |
| Feldman et al. (1995) [ | 33 | 5 | 100 | 96 | - | - |
| Athanasou et al. (1995) [ | 106 | 1 | 90 | 96 | 88 | 98 |
| Lonner et al. (1996) [ | 175 | 5 | 84 | 96 | 70 | 98 |
| Lonner et al. (1996) [ | 175 | 10 | 84 | 99 | 89 | 98 |
| Pace et al. (1997) [ | 25 | 5 | 82 | 93 | 90 | 87 |
| Abdul-Karim et al. (1998) [ | 64 | 5 | 43 | 97 | - | - |
| Spangehl et al. (1999) [ | 202 | 5 | 80 | 94 | 74 | 96 |
| Pons et al. (1999) [ | 83 | 5 | 100 | 98 | 94 | 100 |
| Della Valle et al. (1999) [ | 64 | 5 | 25 | 98 | 50 | 95 |
| Banit et al. (2002) [ | 121 | 10 (knee and hip) | 67 | 93 | 67 | 93 |
| Banit et al. (2002) [ | 55 | 10 (knee) | 100 | 96 | 82 | 100 |
| Banit et al. (2002) [ | 63 | 10 (hip) | 45 | 92 | 55 | 88 |
| Musso et al. (2003) [ | 45 | 5 | 50 | 95 | 60 | 92 |
| Ko et al. (2005) [ | 40 | 5 | 67 | 97 | 86 | 91 |
| Wong et al. (2005) [ | 40 | 5 | 93 | 77 | 68 | 95 |
| Wong et al. (2005) [ | 40 | 10 | 86 | 85 | 75 | 92 |
| Francés Borrego et al. (2006) [ | 63 | 10 (knee) | 66 | 89 | 81 | 81 |
| Francés Borrego et al. (2006) [ | 83 | 10 (hip) | 50 | 100 | 100 | 95 |
| Bori et al. (2006) [ | 61 | 5 | 50 | 81 | 40 | 86 |
| Nuñez et al. (2007) [ | 136 | 5 | 85 | 87 | 79 | 91 |
| Nilsdotter-Augustinsson et al. (2007) [ | 85 | 5 | 81 | 100 | 100 | 87 |
| Della Valle et al. (2007) [ | 105 | 10 (knee) | 88 | 96 | 91 | 93 |
| Bori et al. (2007) [ | 21 | 5 | 28 | 100 | 100 | 73 |
| Bori et al. (2007) [ | 21 | 1 | 71 | 64 | 50 | 81 |
| Kanner et al. (2008) [ | 132 | 5 | 29 | 95 | 40 | 92 |
| Müller et al. (2008) [ | 37 | Total | 94 | 94 | 97 | 86 |
| Schinsky et al. (2008) [ | 201 | 10 (hip) | 73 | 94 | 82 | 90 |
| Fink et al. (2008) [ | 145 | 5 | 90 | 95 | 88 | 96 |
| Savarino et al. (2009) [ | 31 | 1 | 80 | 100 | 100 | 80 |
| Morawietz et al. (2009) [ | 147 | 23 | 73 | 95 | 91 | 84 |
| Tohtz et al. (2010) [ | 52 | 23 | 86 | 100 | 100 | 94 |
| Miyamae et al. (2013) [ | 86 | 10 | 71 | 89 | 42 | 97 |
| Ahmadi et al. (2013) [ | 227 | 5 (elbow) | 51 | 93 | 60 | 90 |
| Muñoz-Mahamud et al. (2013) [ | 11 | 5 (fracture) | 100 | 55 | 33 | 100 |
| Grosso et al. (2014) [ | 44 | 5 (shoulder) | 57 | 100 | - | - |
| Grosso et al. (2014) [ | 44 | 10 (shoulder) | 73 | 100 | - | - |
| Buttaro et al. (2015) [ | 76 | 5 | 90 | 94 | 87 | 96 |
| Kashima et al. (2015) [ | 76 | 2 | 94 | 97 | - | - |
| Kashima et al. (2015) [ | 76 | 5 | 83 | 97 | - | - |
N: number of patients, PMN: polymorphonuclear neutrophil, S: sensitivity, Sp: specificity, PPV: positive predictive value, NPV: negative predictive value; ≥23 polymorphonuclear leukocytes in ≥10 HPF (400x). In each HPF, a maximum of 10 polymorphonuclear leukocytes were counted. The sum must be between zero and 100.
Figure 1Heavily inflamed granulation tissue in which there are numerous neutrophil polymorphs (>5 per high-power fields) with chloroacetate esterase staining.
Figure 2Frozen section of inflammatory tissue showing chloroacetate esterase staining + neutrophil polymorphs (>5 per high-power fields).
Figure 3An area of capsular tissue showing chloroacetate esterase staining in which there are fewer than 5 neutrophil polymorphs per high-power field.